Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Security class unavailable · CUSIP: 690469101

Event date: 2019-02-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,531,996
Percent of class
11.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001395064-19-000080
Form type
SC 13G/A
Filer
Ovid Therapeutics Inc.
CIK
CIK 1636651
Filed
Nov 22, 2019
Reporting period
Feb 22, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub